1.64%
10.54%
4.59%
-1.11%
0.94%
2.63%
11.23%
165.00165.00160.00160.00155.00155.00150.00150.00145.00145.00140.00140.0011/25/202411/25/202412/6/202412/6/202412/17/202412/17/202412/28/202412/28/20241/8/20251/8/20251/19/20251/19/20251/30/20251/30/20252/10/20252/10/2025
Download SVG
Download PNG
Download CSV

Company Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide.The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.


It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.It serves general public, retail outlets, and distributors.The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension.


This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use.Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand.This segment serves wholesalers, hospitals, and retailers.


The company was founded in 1886 and is based in New Brunswick, New Jersey.

Market Data

Last Price 162.3
Change Percentage 1.64%
Open 159.88
Previous Close 159.68
Market Cap ( Millions) 390757
Volume 12252130
Year High 168.85
Year Low 140.68
M A 50 148.99
M A 200 154.32

Financial Ratios

FCF Yield 4.62%
Dividend Yield 3.06%
ROE 19.87%
Debt / Equity 51.24%
Net Debt / EBIDTA 43.92%
Price To Book 5.46
Price Earnings Ratio 27.77
Price To FCF 21.64
Price To sales 4.4
EV / EBITDA 14.14

News

Business Breakdown

Expected Mid-Term Growth

Segment n°1 -> Innovative Medicine

Expected Growth : 3.5 %

What the company do ?

Innovative Medicine from Johnson & Johnson refers to the development of novel treatments and medicines that address unmet medical needs, improving patient outcomes and transforming healthcare.

Why we expect these perspectives ?

Increasing demand for personalized medicine, advancements in gene editing technologies, and growing investments in R&D are driving the growth of innovative medicines, addressing unmet medical needs and improving patient outcomes.

Segment n°2 -> MedTech

Expected Growth : 4.5 %

What the company do ?

MedTech from Johnson & Johnson is a segment focused on developing innovative medical devices and diagnostic solutions to improve healthcare outcomes.

Why we expect these perspectives ?

Growing demand for minimally invasive surgeries, increasing prevalence of chronic diseases, and advancements in medical technology are driving the growth of MedTech segment.

Johnson & Johnson Products

Product Range What is it ?
Band-Aids Adhesive bandages for wound care
Acuvue Contact Lenses Daily disposable contact lenses for vision correction
Tylenol Pain relief medication for headaches and fever reduction
Motrin Pain relief medication for arthritis and menstrual cramps
Neutrogena Skincare Skincare products for cleansing, moisturizing, and protecting the skin
Depend Adult Incontinence Products Adult incontinence products for bladder control
Sudafed Decongestant medication for relieving nasal congestion
Zytiga Medication for treating prostate cancer
Xarelto Medication for preventing stroke and blood clots
Invega Medication for treating schizophrenia and bipolar disorder

Johnson & Johnson's Porter Forces

Johnson & Johnson has a diverse product portfolio, which reduces the threat of substitutes. However, the company faces competition from generic and biosimilar products, which could erode its market share.

Johnson & Johnson's customers, including hospitals and pharmacies, have limited bargaining power due to the company's strong brand reputation and diversified product offerings.

Johnson & Johnson relies on a network of suppliers for raw materials and components. While the company has some bargaining power, suppliers of critical components may have some negotiating power.

The pharmaceutical and medical device industries have high barriers to entry, including significant R&D investments and regulatory hurdles, which limits the threat of new entrants.

The pharmaceutical and medical device industries are highly competitive, with many established players vying for market share. Johnson & Johnson faces intense competition from companies like Pfizer, Merck, and Medtronic.

Capital Structure

Value
Debt Weight 29.90%
Debt Cost 4.63%
Equity Weight 70.10%
Equity Cost 6.68%
WACC 6.07%
Leverage 42.65%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
MRK Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas …
GILD Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, …
BMY Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, …
ABBV AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat …
AMGN Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
162.3$
Current Price
162.3$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

ValueQualityYieldMomentumVolatilityGrowth
Company A-Score: 8.30Peer Group Average: 4.70Leader: 7.70

Peers Group Analysis

🥇

Gilead Sciences Logo
Gilead Sciences
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

🥈

Bristol-Myers Squibb Logo
Bristol-Myers Squibb
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

🥉

J&J Logo
J&J
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

Merck Logo
Merck
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

AbbVie Logo
AbbVie
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

Amgen Logo
Amgen
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->